• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较骨折风险评估工具评分与骨密度,以评估雄激素剥夺治疗的晚期前列腺癌患者的骨折风险。

Comparison of fracture risk assessment tool score to bone mineral density for estimating fracture risk in patients with advanced prostate cancer on androgen deprivation therapy.

机构信息

Associated Medical Professionals of New York, Syracuse, NY.

SUNY Upstate Medical University, Syracuse, NY.

出版信息

Urology. 2014 Jul;84(1):164-8. doi: 10.1016/j.urology.2013.12.071.

DOI:10.1016/j.urology.2013.12.071
PMID:24976229
Abstract

OBJECTIVE

To estimate the risk of fracture (Fracture Risk Assessment Tool [FRAX] algorithm) because of the development of osteoporosis in prostate cancer patients undergoing androgen deprivation therapy (ADT) for patients who would otherwise not have been identified for treatment by the T score.

METHODS

This study includes men undergoing ADT for prostate cancer at our urology group. Clinical data were collected via chart review. Subjects were evaluated for fracture risk using country specific (for the United States of America) World Health Organization's FRAX. The FRAX calculations were then compared to fracture risk as determined by T score, for a subset of our cohort that received dual-energy X-ray absorptiometry.

RESULTS

Our cohort consisted of 613 patients on ADT, 94 of which had a dual-energy X-ray absorptiometry scan. The FRAX algorithm identified 61.6% patients requiring therapy without bone mass density (BMD), 46.8% with BMD, and 19.14% with T score alone. In addition, positive correlation was found between FRAX with and without BMD as well as T score and FRAX with BMD and without BMD.

CONCLUSION

Our data indicate that many patients who were not found at significant risk for fracture with T score were in fact found to be at risk with the FRAX calculation. The largest proportion of patients was found to be at risk through the FRAX calculation without BMD, followed by FRAX with BMD, followed by T score alone. The utility of FRAX is beneficial in identifying patients that may benefit from effective bone-tropic treatment modalities.

摘要

目的

评估因接受雄激素剥夺治疗(ADT)而发生骨质疏松症的骨折风险(骨折风险评估工具 [FRAX] 算法),这些患者如果不根据 T 评分,原本不会被确定接受治疗。

方法

本研究纳入了在我们泌尿科接受 ADT 治疗前列腺癌的男性。通过病历回顾收集临床数据。使用特定国家(美国)的世界卫生组织 FRAX 评估患者的骨折风险。然后将 FRAX 计算结果与接受双能 X 线吸收法检查的亚组的 T 评分确定的骨折风险进行比较。

结果

我们的队列包括 613 名接受 ADT 的患者,其中 94 名患者接受了双能 X 线吸收法检查。FRAX 算法确定了 61.6%的无需骨密度(BMD)检查就需要治疗的患者、46.8%的有 BMD 检查结果的患者和 19.14%的仅根据 T 评分的患者需要治疗。此外,还发现 FRAX 无论是否有 BMD 以及 T 评分与 FRAX 有 BMD 和无 BMD 之间存在正相关关系。

结论

我们的数据表明,许多 T 评分未发现骨折风险显著增加的患者实际上通过 FRAX 计算被发现存在风险。通过无 BMD 的 FRAX 计算发现的患者比例最大,其次是有 BMD 的 FRAX,其次是单独的 T 评分。FRAX 的应用有助于识别可能受益于有效骨靶向治疗的患者。

相似文献

1
Comparison of fracture risk assessment tool score to bone mineral density for estimating fracture risk in patients with advanced prostate cancer on androgen deprivation therapy.比较骨折风险评估工具评分与骨密度,以评估雄激素剥夺治疗的晚期前列腺癌患者的骨折风险。
Urology. 2014 Jul;84(1):164-8. doi: 10.1016/j.urology.2013.12.071.
2
Bone health management in prostate cancer patients receiving androgen deprivation therapy.接受雄激素剥夺治疗的前列腺癌患者的骨骼健康管理。
J Oncol Pharm Pract. 2012 Mar;18(1):84-90. doi: 10.1177/1078155211402105. Epub 2011 Aug 1.
3
Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values.接受雄激素剥夺治疗的前列腺癌患者骨矿物质密度的长期变化及预测骨折风险,基于初始值进行治疗分层
BJU Int. 2009 Sep;104(6):800-5. doi: 10.1111/j.1464-410X.2009.08483.x. Epub 2009 Mar 11.
4
Treatment thresholds for osteoporosis in men on androgen deprivation therapy: T-score versus FRAX.男性雄激素剥夺治疗中骨质疏松的治疗阈值:T 评分与 FRAX。
Osteoporos Int. 2010 Apr;21(4):647-53. doi: 10.1007/s00198-009-0984-0. Epub 2009 Jun 17.
5
Application of the World Health Organization Fracture Risk Assessment Tool to predict need for dual-energy X-ray absorptiometry scanning in postmenopausal women.应用世界卫生组织骨折风险评估工具预测绝经后女性进行双能X线吸收测定扫描的必要性。
Taiwan J Obstet Gynecol. 2015 Dec;54(6):722-5. doi: 10.1016/j.tjog.2015.10.005.
6
Improving bone health in prostate cancer patients starting androgen deprivation therapy: does Fracture Risk Assessment Tool (FRAX®) enhance stratification and targeted management?改善开始雄激素剥夺治疗的前列腺癌患者的骨骼健康:骨折风险评估工具(FRAX®)是否能增强分层和靶向管理?
Arch Osteoporos. 2022 Nov 15;17(1):143. doi: 10.1007/s11657-022-01185-8.
7
Prevalence of osteopenia and osteoporosis by central and peripheral bone mineral density in men with prostate cancer during androgen-deprivation therapy.雄激素剥夺治疗期间前列腺癌男性患者基于中央和外周骨矿物质密度的骨质减少和骨质疏松患病率
Urology. 2006 Jan;67(1):152-5. doi: 10.1016/j.urology.2005.07.017.
8
Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.年龄、体重指数和血清前列腺特异性抗原与未接受雄激素剥夺治疗的前列腺癌男性的骨质流失相关。
Urology. 2004 Aug;64(2):335-40. doi: 10.1016/j.urology.2004.03.036.
9
Validation of three tools for identifying painful new osteoporotic vertebral fractures in older Chinese men: bone mineral density, Osteoporosis Self-Assessment Tool for Asians, and fracture risk assessment tool.三种用于识别中国老年男性疼痛性新发骨质疏松性椎体骨折工具的验证:骨密度、亚洲人骨质疏松自我评估工具和骨折风险评估工具。
Clin Interv Aging. 2016 Apr 22;11:461-9. doi: 10.2147/CIA.S101078. eCollection 2016.
10
Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancer.雄激素剥夺疗法治疗前列腺癌患者骨折风险算法的应用。
J Urol. 2010 Jun;183(6):2200-5. doi: 10.1016/j.juro.2010.02.022.

引用本文的文献

1
Improving bone health in prostate cancer patients starting androgen deprivation therapy: does Fracture Risk Assessment Tool (FRAX®) enhance stratification and targeted management?改善开始雄激素剥夺治疗的前列腺癌患者的骨骼健康:骨折风险评估工具(FRAX®)是否能增强分层和靶向管理?
Arch Osteoporos. 2022 Nov 15;17(1):143. doi: 10.1007/s11657-022-01185-8.
2
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practice.接受激素剥夺疗法的癌症患者椎体骨折的预测:在实际临床实践中世界卫生组织骨折风险评估工具(FRAX)和骨密度的可靠性。
J Bone Oncol. 2022 Mar 9;33:100421. doi: 10.1016/j.jbo.2022.100421. eCollection 2022 Apr.
3
A prospective longitudinal study to evaluate bone health, implication of FRAX tool and impact on quality of life (FACT-P) in advanced prostate cancer patients.一项前瞻性纵向研究,旨在评估晚期前列腺癌患者的骨骼健康、FRAX工具的意义及其对生活质量(FACT-P)的影响。
Am J Clin Exp Urol. 2021 Jun 15;9(3):211-220. eCollection 2021.
4
Conventional finite element models estimate the strength of metastatic human vertebrae despite alterations of the bone's tissue and structure.传统的有限元模型能够估计转移性人类椎骨的强度,尽管骨骼的组织和结构发生了改变。
Bone. 2020 Dec;141:115598. doi: 10.1016/j.bone.2020.115598. Epub 2020 Aug 20.
5
Efficacy of zoledronic acid in older prostate cancer patients undergoing androgen deprivation therapy.唑来膦酸在接受雄激素剥夺治疗的老年前列腺癌患者中的疗效。
Osteoporos Sarcopenia. 2019 Dec;5(4):128-131. doi: 10.1016/j.afos.2019.11.001. Epub 2019 Nov 22.
6
The effects of metastatic lesion on the structural determinants of bone: Current clinical and experimental approaches.转移病灶对骨骼结构决定因素的影响:当前的临床和实验方法。
Bone. 2020 Sep;138:115159. doi: 10.1016/j.bone.2019.115159. Epub 2019 Nov 21.
7
Implications of the Fracture Risk Assessment Algorithm for the assessment and improvement of bone health in patients with prostate cancer: A comprehensive review.骨折风险评估算法对前列腺癌患者骨健康评估及改善的意义:一项综述
Turk J Urol. 2019 Feb 20;45(4):245-253. doi: 10.5152/tud.2019.11736. Print 2019 Jul.
8
Female Human Spines with Simulated Osteolytic Defects: CT-based Structural Analysis of Vertebral Body Strength.女性人工溶骨性缺陷人脊柱:基于 CT 的椎体强度结构分析。
Radiology. 2018 Aug;288(2):436-444. doi: 10.1148/radiol.2018171139. Epub 2018 Jun 5.
9
Administration of an activin receptor IIB ligand trap protects male juvenile rhesus macaques from simian immunodeficiency virus-associated bone loss.给予激活素受体IIB配体陷阱可保护雄性幼年恒河猴免受猴免疫缺陷病毒相关的骨质流失。
Bone. 2017 Apr;97:209-215. doi: 10.1016/j.bone.2017.01.032. Epub 2017 Jan 26.
10
Bone management in Japanese patients with prostate cancer: hormonal therapy leads to an increase in the FRAX score.日本前列腺癌患者的骨骼管理:激素治疗导致FRAX评分升高。
BMC Urol. 2016 Jun 17;16(1):32. doi: 10.1186/s12894-016-0151-9.